DR5 Antibodies

Santa Cruz Biotechnology provides a broad selection of DR5 monoclonal antibodies for advanced research in apoptosis and cell signaling pathways. DR5 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DR5, also known as death receptor 5, plays a critical role in mediating apoptosis through its interaction with the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). The receptor is essential for regulating cell death and has significant implications in cancer therapy, as it can selectively induce apoptosis in tumor cells while sparing normal cells. Understanding DR5 function is crucial for developing targeted treatments and improving therapeutic strategies in oncology. Researchers worldwide rely on DR5 monoclonal antibodies to investigate cellular mechanisms and pathways involved in programmed cell death. DR5 monoclonal antibodies enable detailed examination of receptor expression patterns across different tissue types and experimental conditions. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific understanding of apoptosis and cancer biology.